+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Amines 1698293-93-4
1698293-93-4,MFCD30828926
Catalog No.:AA01DUI0

1698293-93-4 | 2-isopropyl-4-methylpyridin-3-amine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
97%
in stock  
$6.00   $4.00
- +
250mg
97%
in stock  
$7.00   $5.00
- +
1g
97%
in stock  
$9.00   $6.00
- +
5g
97%
in stock  
$26.00   $18.00
- +
25g
97%
in stock  
$76.00   $53.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA01DUI0
Chemical Name:
2-isopropyl-4-methylpyridin-3-amine
CAS Number:
1698293-93-4
Molecular Formula:
C9H14N2
Molecular Weight:
150.2209
MDL Number:
MFCD30828926
SMILES:
CC(c1nccc(c1N)C)C
Properties

Downstream Synthesis Route
79-37-8   
4-methyl-2-(1-methylethyl)-3-pyridinamine 
  142266-62-4   
2,5,6-trichloro-N-((2-isopropyl-4-methylpyridin-3-yl)carbamoyl)nicotinamide 

[1]Patent:US2019/374542,2019,A1.Locationinpatent:Paragraph0802;0804

[2]Patent:US2018/334454,2018,A1.Locationinpatent:Paragraph0578

[3]Patent:US2019/77801,2019,A1.Locationinpatent:Paragraph0215;0218

[4]JournalofMedicinalChemistry,2020

[1]CurrentPatentAssignee:AMGENINC-US2019/374542,2019,A1Locationinpatent:Paragraph0797;0799

[2]CurrentPatentAssignee:INCYTECORP-WO2022/47093,2022,A1Locationinpatent:Page/Pagecolumn88

[3]CurrentPatentAssignee:AMGENINC-WO2020/102730,2020,A1Locationinpatent:Page/Pagecolumn51-52;54;57-58

[4]CurrentPatentAssignee:AMGENINC-US2018/334454,2018,A1Locationinpatent:Paragraph0586

[5]CurrentPatentAssignee:AMGENINC-US2019/77801,2019,A1Locationinpatent:Paragraph0232;0234

[6]CurrentPatentAssignee:BEBETTERMED;GUANGZHOUBEBETTERMEDICINETECH-CN112159405,2021,ALocationinpatent:Paragraph0182;0186

[7]CurrentPatentAssignee:SHOUYAOHOLDINGSBEIJINGCOLTD-CN112574199,2021,ALocationinpatent:Paragraph0348;0352

[8]CurrentPatentAssignee:BIOTHERYXINC-WO2021/51034,2021,A1Locationinpatent:Paragraph0333;0336

[9]CurrentPatentAssignee:REVOLUTIONMEDICINESINC-WO2021/108683,2021,A1Locationinpatent:Page/Pagecolumn214-215

[10]CurrentPatentAssignee:JACOBIOPHARMACEUTICALSGROUPCOLTD-WO2021/185233,2021,A1Locationinpatent:Page/Pagecolumn29

[11]CurrentPatentAssignee:JACOBIOPHARMACEUTICALSGROUPCOLTD-WO2021/185233,2021,A1Locationinpatent:Page/Pagecolumn28-29

[12]CurrentPatentAssignee:SHANGHAIZHEYEBIOTECHNOLOGY-WO2022/28346,2022,A1Locationinpatent:Page/Pagecolumn22

[13]CurrentPatentAssignee:HANGZHOUPOLYMEDBIOPHARMACEUTICALS-WO2022/111521,2022,A1Locationinpatent:Page/Pagecolumn164-165

126325-50-6    77047-87-1   
4-methyl-2-(1-methylethyl)-3-pyridinamine 

[1]Patent:US2019/374542,2019,A1

[2]Patent:US2019/374542,2019,A1

[3]JournalofMedicinalChemistry,2020,vol.63,p.52-65

[4]Patent:US2018/334454,2018,A1.Locationinpatent:Paragraph0577

[5]Patent:US2019/77801,2019,A1.Locationinpatent:Paragraph0215;0217

[6]Patent:US2019/375749,2019,A1.Locationinpatent:Paragraph0211;0212

[7]Patent:US2019/345169,2019,A1.Locationinpatent:Paragraph0253-0254

[1]CurrentPatentAssignee:AMGENINC-US2018/334454,2018,A1

[2]Lanman,BrianA.;Allen,JenniferR.;Allen,JohnG.;Amegadzie,AlbertK.;Ashton,KateS.;Booker,ShonK.;Chen,JianJeffrey;Chen,Ning;Frohn,MichaelJ.;Goodman,Guy;Kopecky,DavidJ.;Liu,Longbin;Lopez,Patricia;Low,JonathanD.;Ma,Vu;Minatti,AnaE.;Nguyen,ThomasT.;Nishimura,Nobuko;Pickrell,AlexanderJ.;Reed,AnthonyB.;Shin,Youngsook;Siegmund,AaronC.;Tamayo,NuriaA.;Tegley,ChristopherM.;Walton,MaryC.;Wang,Hui-Ling;Wurz,RyanP.;Xue,May;Yang,KevinC.;Achanta,Pragathi;Bartberger,MichaelD.;Canon,Jude;Hollis,L.Steven;McCarter,JohnD.;Mohr,Christopher;Rex,Karen;Saiki,AnneY.;SanMiguel,Tisha;Volak,LaurieP.;Wang,KevinH.;Whittington,DouglasA.;Zech,StephanG.;Lipford,J.Russell;Cee,VictorJ.[JournalofMedicinalChemistry,2020,vol.63,#1,p.52-65]

[3]CurrentPatentAssignee:AMGENINC-WO2020/106647,2020,A2

[4]CurrentPatentAssignee:AMGENINC-WO2020/106647,2020,A2

[5]CurrentPatentAssignee:AMGENINC-WO2020/106647,2020,A2

[6]CurrentPatentAssignee:AMGENINC-WO2020/106647,2020,A2

[7]CurrentPatentAssignee:AMGENINC-WO2021/97207,2021,A1

[1]CurrentPatentAssignee:AMGENINC-US2019/374542,2019,A1Locationinpatent:Paragraph0868-0869;0903-0904

[2]CurrentPatentAssignee:AMGENINC-US2019/345169,2019,A1Locationinpatent:Paragraph0271-0272

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1698293-93-4
2460754-74-7

2460754-74-7

 126553-00-2

126553-00-2

 38222-83-2

38222-83-2

 405103-02-8

405103-02-8

 39919-70-5

39919-70-5

 133980-64-0

133980-64-0
Building Blocks
More >
Tags:1698293-93-4 Molecular Formula|1698293-93-4 MDL|1698293-93-4 SMILES|1698293-93-4 2-isopropyl-4-methylpyridin-3-amine